Glenmark gets marketing approval for Ryaltris in 13 EU, UK countries

Mumbai: Global pharma company, Glenmark Pharmaceuticals Limited, has recently announced that the company has received marketing approval for its fixed-dose combination nasal spray Ryaltris in 13...

Related Keywords

Malaysia ,Australia ,Philippines ,United Kingdom ,Uzbekistan ,Brazil ,China ,Czech Republic ,Yuhan ,Anhui ,South Africa ,Canada ,Russia ,Zambia ,Ukraine ,Mumbai ,Maharashtra ,India ,Ecuador ,Saudi Arabia ,Peru ,South Korea ,Poland ,Robert Crockart ,Agency Complete Response Letter ,Drug Administration ,Glenmark Pharmaceuticals ,Yuhan Corporation ,Seqirus Pty Ltd ,Menarini Group ,Hikma Pharmaceuticals ,Bausch Health ,China Co ,Glenmark Pharmaceuticals Limited ,Chief Commercial Officer ,Complete Response Letter ,Grand Pharmaceutical ,Seqirus Pty ,Glenmark ,Glenmark News ,Ryaltris ,Allergic Rhinitis ,Hikma Pharma ,